logo

MDXH

MDxHealth·NASDAQ
--
--(--)
--
--(--)
3.58 / 10
Netural

Fund flow evaluation is robust at 7.16/10, with positive Small and Medium trends despite overall block outflows. Analyst sentiment is overwhelmingly bullish (100% Strong Buy from one report), yet historical win rates are low (0.0%), and the current price trend is falling (-8.85%). This divergence between positive money flow and weak analyst reliability adds uncertainty to near-term momentum.

FundamentalSentiment(3.58)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-12-23
InstitutionBTIG
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for MDXH?
  • MDXH holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.58/10 (Netural).